Acurx Pharmaceuticals (ACXP) Misses Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts ACXP Hot Sheet
Join SI Premium – FREE
Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q1 EPS of ($0.28), $0.04 worse than the analyst estimate of ($0.24).
For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
